- Home
- Solutions
- Consulting
- Asset development
- Dose optimisation strategies
Dose optimisation strategies
Comprehensive PK / PD modelling and simulation
Optimising the dose and dosing regimen is a key step in the overall development program
ICON provides a comprehensive range of pharmacokinetic (PK) and pharmacodynamic (PD) modelling and simulation, either as individual components or as part of an integrated package.Our expertise in the application and presentation of PK and PD principles for successful drug approval, includes:
- Developing PK/PD strategy as part of the drug development plan
- Designing PK studies and sub-studies
- Exposure-response modelling
- PK and PK/PD analysis
- Sparse sampling analysis
- Bioequivalence analysis (individual and population)
- In Vitro-In Vivo Correlation (IVIVC)
- PK/PD modeling and simulation
- Clinical trial simulation
- Preparation of stand-alone or integrated summary reports
- Preparing and producing pharmacokinetic and clinical pharmacology reports for all regulatory submissions
To learn more or to speak with an expert, contact us today.
In this section
In this section
- Decentralised Clinical Trial Solutions
- Real World Intelligence
-
Cardiac Safety Monitoring
-
Clinical & Scientific Operations
- Biostatistics
-
Case studies
- Clinical Operations
-
Clinical Supplies Management
- COVID-19
- Clinical data science
-
Endpoint Adjudication Services
- Global Logistics
- Interactive Response Technology
- Investigator Payments
-
Medical Affairs
-
Medical Call Centre Services
-
Medical Writing & Publishing
- Pharmacovigilance
-
Project and Program Management
-
Site Identification and Feasibility
-
Consulting
- Early Clinical
-
Laboratories
- Language Services
- Medical Imaging
- Site & Patient Solutions
- Strategic Solutions
- Symphony Health
-
Technologies
-
Decentralised Clinical Trial Solutions